SICAGEN INDIA LTD. - 533014 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of loss of Share Certificate.15-06-2023
15-06-2023
SICAGEN INDIA LTD. - 533014 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Pursuant to the Regulation 24A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. CIR/CFD/CMD1/27/2019 dated February 08, 2019, please find attached herewith the Annual Secretarial Compliance Report for the year ended on March 31, 2023, duly signed & issued by M/s. KRA & Associates, Practicing Company Secretaries, Chennai.30-05-2023
SICAGEN INDIA LTD. - 533014 - Disclosure On Related Party Transactions By Sicagen India Limited (''The Company'') For The Half Year Ended March 31, 2023
Disclosure On Related Party Transactions By Sicagen India Limited (''The Company'') For The Half Year Ended March 31, 202322-05-2023
SICAGEN INDIA LTD. - 533014 - Board Meeting Outcome for Dividend 2022-23
The Board of Directors at its meeting held on today, has recommended the Dividend for the Financial Year 2022-23 is 6% i.e. (60 paise per share) on the Equity Capital of the Company subject to the approval of shareholders at the ensuing Annual General Meeting.22-05-2023
SICAGEN INDIA LTD. - 533014 - Audited Financial Results For The Quarter & Year Ended 31.03.2023
In the meeting of Board of Directors of the Company held on 22.05.2023, i.e. today, the Board has inter alia considered and approved the Audited Financial Results for the quarter & year ended 31.03.2023 together with the Auditors Report thereon. The board has also recommended 6% dividend (.60 paise per share) on Equity Capital of the Company for the financial year 2022-23.22-05-2023
SICAGEN INDIA LTD. - 533014 - Board Meeting Intimation for Board Meeting Intimation For Considering Audited Financial Results For The Quarter And Year Ended 31St March 2023.
SICAGEN INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/05/2023 ,inter alia, to consider and approve the Audited Financial Results and Audited Financial Statements for the year ended 31st March, 2023 and recommendation of Equity Dividend if any for the FY 2022-23.11-05-2023
SICAGEN INDIA LTD. - 533014 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanySICAGEN INDIA LTD. 2CIN NO.L74900TN2004PLC053467 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.00 4Highest Credit Rating during the previous FY 0 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Ankita Jain Designation: Company Secretary EmailId: [email protected] Name of the Chief Financial Officer: MO Ayyappan Designation: Chief Financial Officer EmailId: [email protected] Date: 10/05/2023 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.10-05-2023
SICAGEN INDIA LTD. - 533014 - Announcement under Regulation 30 (LODR)-Scheme of Arrangement
With reference to our earlier communication dated 11.02.2022 regarding submission of draft Scheme of Amalgamation, we would like to inform you that the Hon'ble National Company Law Tribunal had directed, for serving notice about the date of hearing as 21st June 2023, pursuant to Rule 16 of The Companies (Compromises, Arrangements and Amalgamations) Rules, 2016, on the above subject. The relevant documents are attached. This is for your information & record please.08-05-2023
SICAGEN INDIA LTD. - 533014 - Compliance Under Regulation 40(10) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015
Pursuant to captioned regulation, please find enclosed herewith a copy of the certificate, received from a Company Secretary in Practice as required under Regulation 40(9) of the Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, for the year ended on March 31, 2023.24-04-2023